1. Home
  2. GLPG vs NWN Comparison

GLPG vs NWN Comparison

Compare GLPG & NWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLPG
  • NWN
  • Stock Information
  • Founded
  • GLPG 1999
  • NWN 1859
  • Country
  • GLPG Belgium
  • NWN United States
  • Employees
  • GLPG N/A
  • NWN N/A
  • Industry
  • GLPG Biotechnology: Pharmaceutical Preparations
  • NWN Oil/Gas Transmission
  • Sector
  • GLPG Health Care
  • NWN Utilities
  • Exchange
  • GLPG Nasdaq
  • NWN Nasdaq
  • Market Cap
  • GLPG 1.8B
  • NWN 1.6B
  • IPO Year
  • GLPG 2005
  • NWN N/A
  • Fundamental
  • Price
  • GLPG $29.92
  • NWN $41.44
  • Analyst Decision
  • GLPG Sell
  • NWN Strong Buy
  • Analyst Count
  • GLPG 4
  • NWN 3
  • Target Price
  • GLPG $25.33
  • NWN $46.33
  • AVG Volume (30 Days)
  • GLPG 226.8K
  • NWN 366.9K
  • Earning Date
  • GLPG 07-23-2025
  • NWN 08-01-2025
  • Dividend Yield
  • GLPG N/A
  • NWN 4.73%
  • EPS Growth
  • GLPG N/A
  • NWN 11.40
  • EPS
  • GLPG N/A
  • NWN 2.61
  • Revenue
  • GLPG $311,493,731.00
  • NWN $1,213,808,000.00
  • Revenue This Year
  • GLPG $0.78
  • NWN $16.91
  • Revenue Next Year
  • GLPG N/A
  • NWN $6.75
  • P/E Ratio
  • GLPG N/A
  • NWN $15.89
  • Revenue Growth
  • GLPG 18.32
  • NWN 3.88
  • 52 Week Low
  • GLPG $22.36
  • NWN $35.11
  • 52 Week High
  • GLPG $31.23
  • NWN $44.38
  • Technical
  • Relative Strength Index (RSI)
  • GLPG 62.12
  • NWN 58.23
  • Support Level
  • GLPG $28.21
  • NWN $40.38
  • Resistance Level
  • GLPG $29.23
  • NWN $41.74
  • Average True Range (ATR)
  • GLPG 0.53
  • NWN 0.78
  • MACD
  • GLPG 0.09
  • NWN 0.21
  • Stochastic Oscillator
  • GLPG 93.93
  • NWN 87.60

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.

About NWN Northwest Natural Holding Company

Northwest Natural Holding Co is a public natural gas service supplier operating in the U.S. Pacific Northwest. Its subsidiary, NW Natural, operates through the natural gas distribution segment, which purchases and distributes natural gas through which operates in Oregon and southwest Washington. The company operates in one reportable business segment, which is NW Natural's local gas distribution business and is referred to as the NGD segment. The company generates its revenue from residential, commercial, and industrial customers, the majority of which are in Oregon. Residential and commercial customers account for the vast majority of profitability.

Share on Social Networks: